Catheter Precision (VTAK) Equity Ratio (2017 - 2025)
Catheter Precision (VTAK) has disclosed Equity Ratio for 9 consecutive years, with 0.25 as the latest value for Q3 2025.
- On a quarterly basis, Equity Ratio fell 47.21% to 0.25 in Q3 2025 year-over-year; TTM through Sep 2025 was 0.25, a 47.21% decrease, with the full-year FY2024 number at 0.42, down 38.6% from a year prior.
- Equity Ratio was 0.25 for Q3 2025 at Catheter Precision, down from 0.26 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.8 in Q3 2021 to a low of 0.25 in Q3 2025.
- A 5-year average of 0.58 and a median of 0.66 in 2021 define the central range for Equity Ratio.
- Peak YoY movement for Equity Ratio: rose 27.19% in 2022, then plummeted 53.01% in 2025.
- Catheter Precision's Equity Ratio stood at 0.65 in 2021, then dropped by 15.35% to 0.55 in 2022, then rose by 25.36% to 0.69 in 2023, then plummeted by 38.6% to 0.42 in 2024, then plummeted by 40.2% to 0.25 in 2025.
- Per Business Quant, the three most recent readings for VTAK's Equity Ratio are 0.25 (Q3 2025), 0.26 (Q2 2025), and 0.32 (Q1 2025).